HLA B 27 disease association

Alphabetical Test listing

HLA B 27 disease association-13340

Test name:

Test number:

13340

Excellian order number:

LAB13340

Abbreviation:

B27

Alternate names:

B27 Disease Association
HLA Antigen B27
Ankylosing spondylitis
Reactive arthritis
Uveitis

Useful for:

Evaluate spondyloarthritis and other disorders associated with HLA-B27.

Specimen type:

EDTA whole blood

Collection container:

Lavender (EDTA), 4mL

Volume:

4.0 mL

Minimum volume:

0.5 mL

Collection instructions:

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

Transport container:

Lavender (EDTA), 4mL

Transport and stability:

Ambient

Reason for rejection:

Hemolysis
Clotted specimen
Tubes other than lavender-top (EDTA) tube

Performing lab:

LabCorp Burlington DNA (006924): R-LC

Days set up:

Mo - Sa

TAT:

4 - 7 days

Method:

Polymerase chain reaction (PCR)/sequence-specific oligonucleotide probes (SSOP)

Reference ranges:

The generic sequence coding for HLA-B27 is probed and reported as either P (positive) if it is present, or N (negative) if it is absent

Preauthorization:

This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.

CPT codes:

81374

Subject to medical necessity (Y/N):

Yes

LOINC code:

Result 26043-0

Other billing information:

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
All information requested is required in order for your request to be completed

Molecular Medicare billing request

Date created:

04/08/2019

Revised date:

03/30/2021

Review date:

07/12/2023